IDNA Genomics Public Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023
Period Ending	Mar '26 Mar 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Market Capitalization	63	76	76
Enterprise Value	66	79	-
Last Close Price	23.00	27.60	27.60
PS Ratio	123.83	159.33	154.54
PB Ratio	-38.97	-114.72	31.70
EV/Sales Ratio	127.96	165.71	-
Debt / Equity Ratio	-1.55	-4.08	1.31
Net Debt / Equity Ratio	-1.45	-3.47	1.27
Net Debt / EBITDA Ratio	-1.44	-1.76	-2.71
Net Debt / FCF Ratio	-0.85	-0.91	-235.90
Asset Turnover	-	0.09	-
Inventory Turnover	-	1.49	-
Quick Ratio	0.21	0.36	0.20
Current Ratio	0.29	0.47	0.29
Return on Equity (ROE)	-	-341.88%	-
Return on Assets (ROA)	-	-17.80%	-
Return on Capital Employed (ROCE)	244.50%	-325.00%	-23.00%
Earnings Yield	-3.96%	-3.31%	-1.76%
FCF Yield	-4.36%	-3.32%	-0.02%

Source: S&P Capital IQ. Standard template. Financial Sources.